About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials in Houston | 123 Studies

Clinical Trials HIV/AIDSHouston

HIV/AIDS Clinical Trials in Houston

Find 123 clinical trials for hiv/aids near Houston, Texas. Connect with research centers in your area.

All HIV/AIDS trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 123 trials

TerminatedTreatment of Chronic Cryptosporidiosis in AIDS PatientsThe purpose of this study is to see if it is safe and effective to add interleukin-12 (IL-12) to the standard drug combination (paromomycin plus azithromycin) used to treat…NCT00001128·Houston, Texas CompletedA Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral RegimenThis study is a 48-week, Phase IIIb, randomly assigned, open-label, active-controlled, multicenter, parallel group, non-inferiority study.NCT02105987·Phoenix, Arizona and 102 others

HIV/AIDS Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedThe Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionThis double-blind, placebo-controlled study is designed to determine the long-term safety and efficacy of concurrent oral Retrovir / Zovirax (AZT and ACV) therapy and oral AZT…NCT00002290·Birmingham, Alabama and 13 others

CompletedA Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected ChildrenThe purpose of this study is to determine the safety and maximum tolerated dose (the highest dose that can be given safely) of recombinant Interleukin-2 (rIL-2) in HIV-infected…NCT00000849·Long Beach, California and 13 others

CompletedA Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1The purpose of this study is to evaluate the safety and tolerability of TMC435 along with pegylated interferon alpha-2a (PegIFNα-2a) and ribavirin (RBV) triple therapy in…NCT01479868·Los Angeles, California and 31 others

CompletedA Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.A study of the efficacy and safety of the combination of daclatasvir and sofosbuvir in the treatment of hepatitis C virus and HIV coinfection.NCT02032888·Birmingham, Alabama and 36 others

CompletedInduction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 InfectionThis study was designed to test the efficacy, safety, tolerability and durability of the antiviral response between atazanavir (ATV) + ritonavir (/r) +…NCT00440947·Phoenix, Arizona and 71 others

CompletedB-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-BThe purpose of this study was to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations of people living with HIV: prior HBV vaccine recipients who…NCT04193189·Birmingham, Alabama and 40 others

CompletedAttitudes and Beliefs and the Steps of HIV CareThrough a prospective observational cohort study enrolling patients newly diagnosed with Human immunodeficiency virus (HIV): Aim 1: Assess attitudes and beliefs about HIV disease…NCT00749840·Houston, Texas

TerminatedHost Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)Background: Over 80% of the hemophiliac population who became infected with HIV prior to 1985 are also co-infected with HCV.NCT00340548·La Jolla, California and 14 others

CompletedH1N1 Vaccine at Two Dose Levels in HIV Positive AdultsThe purpose of this study is to see how the body reacts to different strengths of the H1N1 flu shot in persons infected with human immunodeficiency virus (HIV).NCT00992433·Iowa City, Iowa and 5 others

CompletedA Study of Zidovudine in HIV-Infected Patients Who Have HemophiliaStudy A: To determine whether treatment with zidovudine (ZDV) will delay or change the disease process in hemophilic patients who have HIV infection with no symptoms.NCT00001104·Los Angeles, California and 22 others

CompletedExamining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected AdultsOral human papillomavirus (HPV) and oral warts are common health concerns for HIV-infected people.NCT01029249·Birmingham, Alabama and 34 others

CompletedEvaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV InfectionHepatitis C virus (HCV) infection is a leading cause of death and illness in people with HIV-1.NCT01482767·Birmingham, Alabama and 42 others

CompletedSafety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV VirusThe purpose of this open label study is to evaluate the safety and efficacy of daclatasvir plus pegylated interferon-alfa 2a and ribavirin in untreated hepatitis C virus in…NCT01471574·Birmingham, Alabama and 85 others

CompletedSafety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 InfectionThe main objective of this study is to observe the long-term safety of elvitegravir (EVG) boosted with ritonavir (RTV) in combination with other antiretroviral (ARV) agents in…NCT00445146·Pheonix, Arizona and 47 others

RecruitingThis Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.This study will evaluate the clinical performance of two investigational diagnostic kits developed by ALPCO: the Syphilis-T CLIA Kit and the Syphilis-NT CLIA Kit.NCT07089836·Lancaster, California and 5 others

CompletedStudy to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)This study will evaluate how safe Budigalimab is and how it moves within the body in adult participants with HIV-1 infection.NCT04799353·Bakersfield, California and 9 others

CompletedStudy Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)The purpose of this study is to compare the safety, tolerability, and antiviral activity of the lopinavir/ritonavir tablet when administered in combination with reverse…NCT00711009·Phoenix, Arizona and 36 others

RecruitingA Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIVThis study will test a new ribonucleic acid (RNA)-based vaccine called BNT168 in adults living both with and without human immunodeficiency virus (HIV), to see how safe it is, how…NCT07698600·Houston, Texas

PreviousPage 2 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia